NEUROGENE INC.
Registration details
Company overview
NEUROGENE INC. is a registered legal entity registered in United States under 4359857, and its current status with Delaware Division of Corporations is active. The company was incorporated on 5 January 2009 and lists its registered address as United States. 5 shareholders are on record for NEUROGENE INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
5
Registry notes and limitations
The Chief Medical Officer of NEUROGENE INC. currently on record is Julie Jordan M.d.; five officers are currently on record for NEUROGENE INC., filed with Delaware Division of Corporations.
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at NEUROGENE INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Frequently asked questions
Who owns NEUROGENE INC.?
Five shareholders are currently on record for NEUROGENE INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 5.3% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is NEUROGENE INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for NEUROGENE INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does NEUROGENE INC. have on record?
5 shareholders are shown on record for NEUROGENE INC..
What is NEUROGENE INC.'s company registration number?
NEUROGENE INC.'s registration number is 4359857, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is NEUROGENE INC. still an active company?
NEUROGENE INC.'s status on Delaware Division of Corporations is listed as active.
When was NEUROGENE INC. incorporated?
NEUROGENE INC. was incorporated on 5 January 2009, according to Delaware Division of Corporations.
What is NEUROGENE INC.'s registered address?
The registered address on file for NEUROGENE INC. is United States.
Who are the officers/directors of NEUROGENE INC.?
The Chief Medical Officer of NEUROGENE INC. currently on record is Julie Jordan M.d.; five officers are currently on record for NEUROGENE INC., filed with Delaware Division of Corporations. Management authority at NEUROGENE INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.